May 3 (Reuters) - Hemostemix Inc:
* HEMOSTEMIX ANNOUNCES FIRST PATIENT TREATED IN PHASE II CLINICAL TRIAL
* HEMOSTEMIX INC - ANNOUNCES DEPARTURE OF DAVID BERMAN FROM POSITION OF CHIEF FINANCIAL OFFICER
* HEMOSTEMIX INC - KRISTIN GULKA JOINS HEMOSTEMIX IN CAPACITY OF CFO Source text for Eikon: Further company coverage: